Pharmacokinetics of Cannabidiol in the Hispaniolan Amazon Parrot (

Amazona ventralis CBD Hispaniolan Amazon parrot avian cannabidiol cannabinoids pain pharmacokinetics

Journal

Journal of avian medicine and surgery
ISSN: 1082-6742
Titre abrégé: J Avian Med Surg
Pays: United States
ID NLM: 9512497

Informations de publication

Date de publication:
Aug 2022
Historique:
entrez: 16 8 2022
pubmed: 17 8 2022
medline: 19 8 2022
Statut: ppublish

Résumé

The purpose of this study was to determine the pharmacokinetics of cannabidiol (CBD), a potential treatment option that may alleviate pain in companion animals and humans, in the Hispaniolan Amazon parrot (

Identifiants

pubmed: 35972864
doi: 10.1647/20-00076
doi:

Substances chimiques

Plant Extracts 0
Cannabidiol 19GBJ60SN5
hempseed oil 69VJ1LPN1S

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-127

Références

Hartsel JA, Boyar K, Pham A, et al. Cannabis in veterinary medicine: cannabinoid therapies for animals. In: Gupta RC, Srivastava A, Lall R, eds.
Brutlag A, Hommerding H. Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats.
Long EL, Malone D, Taylor D. The pharmacological effects of cannabidiol.
Gamble LJ, Boesch JM, Frye CW, et al. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs.
Verrico CD, Wesson S, Konduri V, et al. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.
AVMA Council on Biologic and Therapeutic Agents. Cannabis use and pets: what veterinarians need to know. American Veterinary Medical Association. Accessed April 14, 2020.https://www.avma.org/resources-tools/veterinarians-and-public-health/cannabis-use-and-pets
Mechoulam R, Parker L, Gallily R. Cannabidiol: an overview of some pharmacological aspects.
Zurier RB, Burstein SH. Cannabinoids, inflammation, and fibrosis.
Landa L, Sulcova A, Gbelec P. The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review.
Bartner LR, McGrath S, Rao S, et al. Pharmacokinetics of cannabidiol administration by 3 delivery methods at 2 different dosages to healthy dogs.
Deabold KA, Schwark WS, Wolf L, et al. Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats.
Wakshlag JJ, Schwark WS, Deabold KA, et al. Pharmacokinetics of cannabidiol, cannabidiolic acid, Δ9-tetrahydrocannabinol, tetrahydrocannabinolic acid and related metabolites in canine serum after dosing with three oral forms of hemp extract.
Devinksy O, Patel AD, Thiele EA, et al. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.

Auteurs

James W Carpenter (JW)

Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA, carpentr@vet.ksu.edu.

Thomas N Tully (TN)

Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.

Kelly Rockwell (K)

Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.

Butch KuKanich (B)

Institute of Computational Comparative Medicine and Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH